ANTIMETABOLIC DRUG

Brand Owner (click to sort) Address Description
IMURAN SEBELA IRELAND LIMITED PETER STREET DUBLIN 8 Ireland Antimetabolic Drug;
IMURAN SEBELA INTERNATIONAL BERMUDA LIMITED H.P. HOUSE, 21 LAFFAN STREET HAMILTON HM 09 Bermuda Antimetabolic Drug;
IMURAN SEBELA INTERNATIONAL LIMITED H.P. House 21 Laffan Street Hamilton HM09 Bermuda Antimetabolic Drug;
PURINETHOL STASON PHARMACEUTICALS, INC. 11 Morgan Irvine CA 92618 ANTIMETABOLIC DRUG;
PURINETHOL TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY PALLAGI UT 13-15 DEBRECEN H-4042 Hungary ANTIMETABOLIC DRUG;
PURINETHOL BIOGAL PHARMACEUTICALS WORKS LTD. PALLAGI UT 13 -15 DEBRECEN H-4042 Hungary ANTIMETABOLIC DRUG;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A solid drug perforator (SSP) system and an associated drug reservoir are provided for delivering theraputic, prophylactic and/or cosmetic compounds, for nutrient delivery and for drug targeting. For drug delivery, the SSP system includes an active drug ingredient and a matrix of perforator material that biodegrades or dissolves quickly upon contact with a patient's body. The SSP system provides a skin barrier perforator and a controller for prompt initiation and cut-off of drug delivery. In a preferred method of transdermal drug delivery, an SSP system containing a selected drug penetrates into an epidermis or dermis, and the drug is promptly released from the (dissolving) SSP system perforator. An additional drug is optionally delivered from a patch reservoir through skin pores created by insertion of the perforator. Formulation and fabrication procedures for the SSP and associated reservoir are also provided. An SSP system can be fabricated with variety of shapes and dimensions.